The question of whether VKORC1 directly contributes to longevity cannot be answered affirmatively with current evidence. VKORC1 encodes an enzyme that reduces vitamin K, thereby regulating blood coagulation. The gene is best known for its role in individualizing dosing of vitamin K antagonists like warfarin. Some studies explore possible links between VKORC1 variants and cardiovascular risk or bone health, but the effects are small and not consistent enough to make a direct claim about lifespan extension. Longevity is a multifactorial trait where diet, exercise, sleep, and social factors play a much larger role than single gene variants. Consumer DNA tests tend to overstate such associations. Anyone aiming to improve longevity should focus on evidence-based lifestyle interventions rather than isolated genetic markers. The evidence for VKORC1 in this context is best described as unclear or mechanistic at best.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-2cfce1615b04bd77e49c22e1